Cargando…

Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern Ireland

Medicines optimisation for those with respiratory conditions can have a significant impact on clinical outcomes and substantial efficiency gains for health care. Consultant pharmacists are experts working at the top of their specialism in four main pillars of practice, namely clinical care, leadersh...

Descripción completa

Detalles Bibliográficos
Autores principales: Gormley, Cairine, Spargo, Maureen, Fleming, Glenda, Moore, Brendan, Scott, Michael, Sharkey, Rose, Friel, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629016/
https://www.ncbi.nlm.nih.gov/pubmed/34842802
http://dx.doi.org/10.3390/pharmacy9040177
_version_ 1784607120174350336
author Gormley, Cairine
Spargo, Maureen
Fleming, Glenda
Moore, Brendan
Scott, Michael
Sharkey, Rose
Friel, Anne
author_facet Gormley, Cairine
Spargo, Maureen
Fleming, Glenda
Moore, Brendan
Scott, Michael
Sharkey, Rose
Friel, Anne
author_sort Gormley, Cairine
collection PubMed
description Medicines optimisation for those with respiratory conditions can have a significant impact on clinical outcomes and substantial efficiency gains for health care. Consultant pharmacists are experts working at the top of their specialism in four main pillars of practice, namely clinical care, leadership, education and training, and research and development. A consultant respiratory pharmacist has recently been appointed at a large Health and Social Care Trust in Northern Ireland to provide expert care and clinical leadership for the medicines optimisation agenda with regards to respiratory care in Northern Ireland. Alongside clinical practice, leadership, and service development, emphasis will be placed on monitoring and evaluating the work of the consultant respiratory pharmacist with a view to gathering the necessary evidence to support the case for further investment in such consultant pharmacist posts in the region. This short communication article outlines some of the clinical and economic factors associated with the decisions to invest in the consultant pharmacist model of care in Northern Ireland
format Online
Article
Text
id pubmed-8629016
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86290162021-11-30 Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern Ireland Gormley, Cairine Spargo, Maureen Fleming, Glenda Moore, Brendan Scott, Michael Sharkey, Rose Friel, Anne Pharmacy (Basel) Communication Medicines optimisation for those with respiratory conditions can have a significant impact on clinical outcomes and substantial efficiency gains for health care. Consultant pharmacists are experts working at the top of their specialism in four main pillars of practice, namely clinical care, leadership, education and training, and research and development. A consultant respiratory pharmacist has recently been appointed at a large Health and Social Care Trust in Northern Ireland to provide expert care and clinical leadership for the medicines optimisation agenda with regards to respiratory care in Northern Ireland. Alongside clinical practice, leadership, and service development, emphasis will be placed on monitoring and evaluating the work of the consultant respiratory pharmacist with a view to gathering the necessary evidence to support the case for further investment in such consultant pharmacist posts in the region. This short communication article outlines some of the clinical and economic factors associated with the decisions to invest in the consultant pharmacist model of care in Northern Ireland MDPI 2021-10-30 /pmc/articles/PMC8629016/ /pubmed/34842802 http://dx.doi.org/10.3390/pharmacy9040177 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Gormley, Cairine
Spargo, Maureen
Fleming, Glenda
Moore, Brendan
Scott, Michael
Sharkey, Rose
Friel, Anne
Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern Ireland
title Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern Ireland
title_full Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern Ireland
title_fullStr Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern Ireland
title_full_unstemmed Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern Ireland
title_short Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern Ireland
title_sort medicines optimisation for respiratory patients: the establishment of a new consultant respiratory pharmacist role in northern ireland
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629016/
https://www.ncbi.nlm.nih.gov/pubmed/34842802
http://dx.doi.org/10.3390/pharmacy9040177
work_keys_str_mv AT gormleycairine medicinesoptimisationforrespiratorypatientstheestablishmentofanewconsultantrespiratorypharmacistroleinnorthernireland
AT spargomaureen medicinesoptimisationforrespiratorypatientstheestablishmentofanewconsultantrespiratorypharmacistroleinnorthernireland
AT flemingglenda medicinesoptimisationforrespiratorypatientstheestablishmentofanewconsultantrespiratorypharmacistroleinnorthernireland
AT moorebrendan medicinesoptimisationforrespiratorypatientstheestablishmentofanewconsultantrespiratorypharmacistroleinnorthernireland
AT scottmichael medicinesoptimisationforrespiratorypatientstheestablishmentofanewconsultantrespiratorypharmacistroleinnorthernireland
AT sharkeyrose medicinesoptimisationforrespiratorypatientstheestablishmentofanewconsultantrespiratorypharmacistroleinnorthernireland
AT frielanne medicinesoptimisationforrespiratorypatientstheestablishmentofanewconsultantrespiratorypharmacistroleinnorthernireland